Organ-on-a-chip
is gaining prominence on the backdrop of regulatory measures on
animal testing and growing complexity in therapeutic applications.
Various players are trying to capitalize on lucrative growth
opportunities in the organ-on-a-chip devices market. It is a unique
cell culture process, wherein biomimetic microsystem is used as a
platform.
These
devices are built on silicone, which can be used to grow internal
organs. This finds application in organ transplantation and also
therapeutics. Harvard’s Wyss Institute is engaged in lung-on-chip
production, commercialization of which would help in exponential
growth of the organ-on-a-chip market. Moreover, partnerships of
biotech and pharmaceutical companies with universities is expected to
scale up the commercialization process in the near future. This
billion dollar industry is expected to create significant market
opportunities for players. Some companies such as Mimetas are
currently engaged in development of kidney-on-a-chip. This technology
is gaining traction as this unique technology greatly reduces the
amount of testing carried out on animals, while providing highly
accurate results.
Get
In-Depth Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/49
Organ-on-a-chip
Market Dynamics
Organ-on-a-chip
is expected to cater to wide range of applications ranging from
disease modelling to patient stratification and phenotypic screening.
Most of the demand is expected to be generated from lung-based organ
culture, followed by kidney application. The technology offers better
clinical examinations compared to petri dishes and animal testing –
helping scientists and companies to better understand the functioning
of internal organs such as the brain and lungs.
Funding
and government initiatives are projected to further boost market
growth in the near future. Though the market is expected to create
substantial opportunities, high cost and early stage in R&D are
some of the factors leading to slow growth of the market. Market is
expected to witness rampant commercialization post-2020.
Organ-on-a-chip
Market - Regional Analysis
North
America and Europe are expected to dominate the overall
organ-on-a-chip market throughout the forecast period. The regions
are early adopters of newly developed technology. Moreover, demand is
expected to be further propelled by large consumer base in these
regions. North America spends over 16% of its GDP on healthcare.
Moreover, various research activities are carried out in the region,
which is home to some of the leading players in the market. Also,
organ transplant rate is high in the region. Growth of the Europe
market is expected to be primarily driven by rising demand for
organ-on-chip in Germany, U.K., and France.
Asia
Pacific is a lucrative market for companies engaged in
organ-on-a-chip industry. However, commercialization is not expected
to take place in early years. As market is still in its early stage,
it would take a few years before companies can expect return on
profit. Japan and China are key markets in Asia Pacific. These
countries account for over half of the pharmaceutical market in Asia
Pacific. Also, these countries are well equipped with technologically
advanced medical devices and research centers.
Organ-on-a-chip
Market - Competitive Landscape
Organovo,
Hepregen, Hurel Corporation, Nortis, TissUse, Tara Biosystems, and
AxoSim are some of the players engaged in organ-on-a-chip market.
These companies are located in North America, with most being
start-ups albeit with major funding and are expected to attain major
commercial success in the near future.
For
More Information, Browse Full Report Here:
https://www.coherentmarketinsights.com/ongoing-insight/organ-on-a-chip-market-49
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment